The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma

American Journal of Surgical Pathology

Volumn 35, Issue 4, 2011, Pages 471-473

  Giordano, Thomas J ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MSRB 2 C570D ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METHODOLOGY; MITOSIS; MITOSIS INDEX; PATHOLOGY; PROGNOSIS; REVIEW;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOSIS; MITOTIC INDEX; PATHOLOGY, SURGICAL; PROGNOSIS;

EID: 79953230062     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31820bcf21     Document Type: Review

References (11)

1. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms: a clinicopathologic study of213 cases. Am J Surg Pathol. 1994;18:535-558. (Pubitemid 24150803)
2. Burgues O, Navarro S, Noguera R, et al. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry. Virchows Arch. 2006;449: 410-420. (Pubitemid 44451315)
3. De Reynies A, Assie G, Rickman DS, et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol. 2009;27:1108-1115.
4. Giordano TJ. Adrenocortical tumors: an integrated clinical, pathologic, and molecular approach at the University of Michigan. Arch Pathol Lab Med. 2010;134:1440-1443.
5. Giordano TJ, Thomas DG, Kuick R, et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol. 2003;162:521-531. (Pubitemid 36267859)
6. Giordano TJ, Kuick R, Else T, et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profil-ing. Clin Cancer Res. 2009;15:668-676.
7. Jeffers MD, Oakes SJ, Richmond JA, et al. Proliferation, ploidy and prognosis in uterine smooth muscle tumours. Histopathology. 1996;29:217-223. (Pubitemid 26302729)
8. Lehr HA, Hansen DA, Kussick S, et al. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol. 1999;30:1314-1320. (Pubitemid 29534293)
9. Miller BS, Gauger PG, Hammer GD, et al. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch Surg. 2010;395: 955-961.
10. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8:163-169. (Pubitemid 14166767)
11. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13:202-206. (Pubitemid 19081702)